LL-37 is derived from a precursor protein called hCAP18, produced by immune and epithelial cells. Once activated, LL-37 helps protect the body by destroying pathogens, promoting wound healing, and even stimulating new tissue growth. What makes LL-37 truly remarkable is that it doesn’t just fight bacteria — it also helps regulate the immune system and accelerate recovery.
How It Is Used in Research Settings
Researchers have investigated LL-37 for its diverse biological roles:
- Antimicrobial studies, showing potent activity against bacteria, viruses, and fungi.
- Wound healing and tissue regeneration, for its ability to promote angiogenesis and collagen synthesis.
- Immune modulation, where it can calm overactive immune responses while strengthening the body’s natural defenses.
- Respiratory and lung health, studied for protection against infection and inflammation in pulmonary conditions.
- Skin and dermatologic research, particularly in psoriasis, eczema, and chronic wounds.
Proposed Uses (Research Areas)
- Chronic wound healing and skin repair.
- Antimicrobial and immune defense enhancement.
- Lung and airway inflammation.
- Autoimmune and inflammatory skin disorders.
- Regenerative medicine and tissue remodeling.
How It Is Dosed in Research Settings
In research settings, LL-37 is used in several ways depending on the area of study:
- Subcutaneous injection: Typical research doses range from 100–500 mcg per injection, depending on desired systemic or local effects.
- Topical formulations: Used in creams or gels for wound and skin healing research.
- Inhalation or nebulization: Studied experimentally for respiratory tract protection and inflammation control.
- Cycle length: Protocols vary — short cycles for acute infections, and longer durations for tissue healing or immune studies.
Important Considerations
- Mechanism: LL-37 is multifunctional — it kills pathogens directly, attracts immune cells to sites of injury, and helps orchestrate the repair process.
- Regenerative potential: Research suggests LL-37 can stimulate stem cell activity, angiogenesis, and tissue remodeling — making it highly relevant in regenerative medicine studies.
- Safety: Generally well-tolerated in research settings, though localized redness or irritation can occur with injection or topical use.
- Regulatory status: LL-37 is not FDA-approved and remains experimental, authorized only for research use.
Disclaimer
This material is provided for educational purposes only and summarizes published research on LL-37.
It is not medical advice. LL-37 is experimental, not FDA-approved, and should be used only in the context of authorized research.
This compound is for research use only.